# A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.

> **NCT03436316** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 78 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD8154

## Key facts

- **NCT ID:** NCT03436316
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2019-07-29
- **Final completion:** 2019-07-29
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2019-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436316, "A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03436316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*